How is this different from keto?

Ketosis. The Atkins induction phase, under about 20 g of carbohydrate a day, is ketogenic, and the programme is designed to move you off it through three later phases. Most trials labelled low carbohydrate measure that later state: in DIETFITS the low carbohydrate arm ended at 30 percent of energy from carbohydrate. The practical difference is lipids. On this pattern LDL shows little to no change across 61 randomised trials. On the ketogenic pattern it rose in several trials and tracked with blood ketone level.

How much more weight will I lose than on a normal diet?

About a kilogram. Across 61 randomised trials and 6,925 people, with energy restriction prescribed similarly in both arms in most of them, the difference was 1.07 kg at three to eight months and 0.93 kg at one to two years. In people with type 2 diabetes it was 1.26 kg and then 0.33 kg. The review's own summary is that there is probably little to no difference up to two years.

Then why do the six-month trials look so good?

Because at six months they are good. One trial found 5.8 against 1.9 kg at six months and another found 12.9 against 6.7 percent of bodyweight at 24 weeks. The same trials at twelve months found 5.1 against 3.1 kg, p = 0.20, and the first investigator to publish a large twelve-month win published a null eleven years later with a better-designed trial. The early advantage is real and it is not durable.

What actually improves and stays improved?

Triglycerides, and HDL. Triglycerides fell 20 percent against 4 percent at six months and 0.84 against 0.31 mmol/L at 24 weeks, and those differences survived adjustment for the weight difference in the trials that tested it. HDL rose or fell less than on the comparator at every time point in a two-year trial. Those are the findings this pattern can claim without qualification.

Is a lot of it just the protein?

Probably a meaningful part of it. The Cochrane review states that its most common comparison, in 24 of 61 trials, was a low carbohydrate high protein diet, over 20 percent of energy from protein, against a control balanced across all three macronutrients. Protein independently increases satiety and preserves lean mass, so those trials measure protein and carbohydrate together and report the result as carbohydrate.

Carbohydrate-restricted13 human studies cited

Atkins and non-ketogenic low carbohydrate

Written by Aaron CuhaReviewed Sep 2026

Also called: Atkins, Low carb, Moderate carbohydrate restriction

A Cochrane review of 61 trials and 6,925 people found about one kilogram of difference against a balanced carbohydrate diet at three to eight months, and about nine hundred grams at one to two years. Triglycerides and HDL move reliably. LDL does not move the way it does on a ketogenic diet, and that is the main practical difference between the two.

What it actually is

Carbohydrate restriction that does not produce or does not maintain ketosis. Atkins as written is a four-phase programme: an induction phase under about 20 g of carbohydrate a day, which is ketogenic, then deliberate weekly reintroduction through ongoing weight loss, pre-maintenance and maintenance phases, ending well above the ketogenic threshold. Most of what the literature calls Atkins or low carbohydrate measures that later state rather than the induction. In A TO Z the Atkins arm was instructed to raise carbohydrate after the first two months. In DIETFITS the healthy low carbohydrate arm reached 30 percent of energy from carbohydrate at twelve months. In the Cochrane review that covers this ground, 42 of 61 trials studied carbohydrate above 50 g a day or under 45 percent of energy, which is low carbohydrate and not ketogenic. If the question you have is about ketosis, blood ketone measurement and the LDL hyper-responder pattern, that is a different pattern with different trials and it has its own entry on this site.

The mechanism its advocates propose

The carbohydrate-insulin argument, stated fairly: dietary carbohydrate raises insulin, insulin suppresses fat release from adipose tissue, and restricting carbohydrate frees that energy and reduces hunger. This pattern adds a second and weaker claim that is specific to it, that carbohydrate restriction short of ketosis still improves triglycerides, HDL and glycaemic control independently of weight loss, so the benefit does not require the difficulty of maintaining ketosis. That second claim has been tested directly against a ketogenic comparator, and it survived better than the first one did.

What happened when calories were controlled

Strongest design available: controlled

Energy intake was matched between groups, so a difference in the result is attributable to the composition of the diet rather than to how much was eaten.

The difference against a balanced carbohydrate diet at matched energy prescription is about one kilogram at three to eight months and shrinks toward nothing by two years. It is statistically real and it is a kilogram. Where energy was actually provided rather than prescribed, the metabolic advantage runs the other way by tens of kilocalories a day.

A 2022 Cochrane review of 61 randomised trials and 6,925 participants is the anchor. In most trials, 45 of 61, the energy prescription or approach to restricting intake was similar in both arms. Without type 2 diabetes: mean difference in body weight minus 1.07 kg (95% CI minus 1.55 to minus 0.59) over three to 8.5 months and minus 0.93 kg (minus 1.81 to minus 0.04) over one to two years, both moderate certainty, both described by the review as little to no difference. With type 2 diabetes: minus 1.26 kg at three to six months and minus 0.33 kg (minus 2.13 to 1.46) at one to two years. Diastolic pressure, HbA1c and LDL over one to two years were also little to no difference.
The most common comparison in that review was a low carbohydrate, balanced fat, high protein treatment diet, meaning over 20 percent of energy from protein, against a control balanced for all three macronutrients, in 24 of 61 trials. That means a substantial part of this evidence base compares a higher protein diet with a normal protein diet and attributes the difference to carbohydrate.
POUNDS LOST prescribed calorie-reduced diets at 65 percent and 35 percent of energy from carbohydrate to 811 adults for two years. Weight loss was 2.9 and 3.4 kg, p > 0.20. Satiety, hunger and satisfaction with the diet were similar across all four arms, and attendance at group sessions predicted weight loss at 0.2 kg per session attended.
Johnston 2006 is the trial that separates this pattern from the ketogenic one. 20 adults, six weeks, intake strictly controlled, ketogenic against non-ketogenic at the same low carbohydrate intake with ketosis verified in blood. Weight loss 6.3 against 7.2 kg (p = 0.324) and fat loss 3.4 against 5.5 kg (p = 0.111), both point estimates favouring the non-ketogenic arm. Neither difference was significant with 20 participants. What it does say is that nothing in the controlled data requires ketosis to get the carbohydrate-restriction result.
Hall and Guo 2017 pooled 32 controlled feeding studies swapping carbohydrate for fat at equal calories and found energy expenditure 26 kcal/day and fat loss 16 g/day both greater on the lower fat diets. That is the opposite direction to a metabolic advantage for carbohydrate restriction, and the magnitude is trivial either way.

What happened when people just ate it

Free-living trials produce a real six-month advantage that does not survive to one year, and the pattern is remarkably consistent across two decades of trials. Samaha 2003 randomised 132 severely obese adults, 39 percent with diabetes, and at six months the low carbohydrate arm had lost 5.8 kg against 1.9 kg (p = 0.002), with triglycerides down 20 against 4 percent (p = 0.001) and insulin sensitivity up 6 against down 3 percent (p = 0.01). 79 of 132 completed. Stern 2004 followed the same people to one year: 5.1 against 3.1 kg, a difference of 1.9 kg with a confidence interval from minus 4.9 to 1.0, p = 0.20, with 34 percent dropout and what the authors call suboptimal adherence. Triglycerides still fell more and HDL fell less, and in the 54 participants with diabetes HbA1c improved more after adjustment, with those metabolic differences surviving adjustment for the weight difference. Yancy 2004 ran 120 overweight hyperlipidaemic volunteers for 24 weeks and got the largest separation in this literature: retention 76 against 57 percent (p = 0.02), weight change minus 12.9 against minus 6.7 percent (p < 0.001), triglycerides minus 0.84 against minus 0.31 mmol/L (p = 0.004), HDL plus 0.14 against minus 0.04 mmol/L (p < 0.001) and LDL not significantly different (p = 0.2). Its own stated limitation is the one to carry: the low carbohydrate group also received nutritional supplements that the low fat group did not, so the arms differed by more than carbohydrate. A TO Z favoured Atkins at twelve months, minus 4.7 kg against minus 1.6 for Zone, minus 2.6 for LEARN and minus 2.2 for Ornish, with only the Atkins against Zone comparison reaching significance. Eleven years later the same investigator ran DIETFITS, larger and with better diet quality in both arms, and got a difference of 0.7 kg that was not significant. Bazzano 2014 favoured low carbohydrate by 3.5 kg at twelve months (p = 0.002). Foster 2003 found a large six-month gap that came to nothing at twelve (p = 0.26), and Foster 2010 over two years with behavioural support in both arms found about 11 kg lost at one year and 7 kg at two with no between-group difference in weight, body composition or bone density at any point. DIRECT, which restricted calories and ran two years with 84.6 percent adherence, put low carbohydrate at 4.7 kg, Mediterranean at 4.4 and low fat at 2.9.

Protein, and whether it confounds the result

Protein is the confounder that runs through this whole pattern and it is quantified here better than anywhere else in this section. The Cochrane review states that the most common comparison it pooled, in 24 of 61 trials, was a low carbohydrate high protein diet meaning over 20 percent of energy from protein, against a control balanced for all three macronutrients. Protein independently increases satiety and preserves lean mass in a deficit, so a substantial fraction of the low carbohydrate literature is measuring a protein effect and labelling it carbohydrate. The trials that clamped protein, and the one that held carbohydrate constant while varying only ketosis, found nothing. Where lean mass was reported at all the picture is mixed: Yancy 2004 found both arms lost far more fat mass than fat free mass, 9.4 against 3.3 kg on low carbohydrate and 4.8 against 2.4 kg on low fat, and Foster 2010 found no difference in body composition between arms at any time point over two years.

The measured intakes behind the protein figures are on the protein page.

What reliably moves

Marker	Direction	From
Triglycerides	Down, and this is the most reliable effect of the pattern	Minus 20 against minus 4 percent at six months (p = 0.001), and minus 0.84 against minus 0.31 mmol/L at 24 weeks (p = 0.004). It survives adjustment for the weight difference in the trials that tested that.
HDL cholesterol	Up, or preserved where the comparator's falls	Plus 0.14 against minus 0.04 mmol/L at 24 weeks (p < 0.001). At one year in a separate trial HDL fell less on low carbohydrate rather than rising (p = 0.025), which is the same direction described differently.
LDL cholesterol	No consistent change, and this is the difference from the ketogenic pattern	Not significantly different at 24 weeks (p = 0.2), and little to no difference over one to two years across 61 randomised trials. On the ketogenic pattern LDL rose in some trials and correlated with blood ketone level. If you are choosing between the two on lipids, this is the distinction that matters.
Body weight at matched energy prescription	Down by about one kilogram more than a balanced carbohydrate diet	Minus 1.07 kg at three to 8.5 months and minus 0.93 kg at one to two years without diabetes, minus 1.26 kg and minus 0.33 kg with it. Moderate certainty across 6,925 participants.
Body weight eaten freely at six months	Down substantially more than low fat	3.9 kg more at six months in one trial and 6.2 percentage points of bodyweight more at 24 weeks in another. The gap closes or disappears by twelve months in almost every trial that ran that long.
HbA1c	Better in some trials with diabetes, and null across the pooled evidence	Improved more in the 54 participants with diabetes in one trial after adjustment, including adjustment for weight. Little to no difference against a balanced carbohydrate diet over one to two years across the randomised literature.
Retention in the trial	Better in some trials, worse in others	76 against 57 percent completion in one 24-week trial (p = 0.02), 34 percent dropout in a one-year trial, and poor adherence with high attrition in both arms of another. This is not a settled property of the pattern.

Long term, and hard outcomes

Two years is the ceiling and by then the advantage is about a kilogram or less. The Cochrane review puts it at minus 0.93 kg in people without type 2 diabetes and minus 0.33 kg in people with it at one to two years, with diastolic pressure, HbA1c and LDL all showing little to no difference over the same window, and its own conclusion is that there is probably little to no difference in weight reduction or cardiovascular risk factors up to two years. No randomised trial of this pattern has measured a cardiovascular event, a fracture or a death as an endpoint. The long-term signal comes from cohorts and it runs against the animal-food version of the pattern specifically. Fung 2010 followed 85,168 women and 44,548 men for 20 to 26 years: an animal-based low carbohydrate score carried a hazard ratio of 1.23 for all-cause mortality comparing extreme deciles, 1.14 for cardiovascular and 1.28 for cancer mortality, while a vegetable-based low carbohydrate score carried 0.80 for all-cause and 0.77 for cardiovascular mortality. Seidelmann 2018 found a U-shaped relationship in 15,428 adults over a median 25 years, with the lowest mortality at 50 to 55 percent of energy from carbohydrate, and in a meta-analysis of 432,179 participants both under 40 percent (HR 1.20) and over 70 percent (HR 1.23) carried higher risk than moderate intake. In that analysis, exchanging carbohydrate for animal fat and protein gave a hazard ratio of 1.18 and exchanging it for plant sources gave 0.82. Two things have to be said about those numbers. They are observational, with all the usual confounding. And a low carbohydrate score computed from a food frequency questionnaire in a cohort where almost nobody was actually doing Atkins is not the same exposure as the diet, which is why they cannot settle the question either.

Citations

Review2022
Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.
Cochrane Database of Systematic Reviews
61 randomised trials, 6,925 participants, energy prescription similar in both arms in 45 of them. Without type 2 diabetes: minus 1.07 kg at three to 8.5 months and minus 0.93 kg at one to two years. With it: minus 1.26 kg and minus 0.33 kg. Little to no difference in diastolic pressure, HbA1c or LDL over one to two years. The most common comparison was a high protein low carbohydrate diet against a macronutrient-balanced control, in 24 of 61 trials.
Human2003
A low-carbohydrate as compared with a low-fat diet in severe obesity.
New England Journal of Medicine
132 severely obese adults, 39 percent with diabetes, six months, 79 completed. Weight minus 5.8 against minus 1.9 kg (p = 0.002), triglycerides minus 20 against minus 4 percent (p = 0.001), insulin sensitivity plus 6 against minus 3 percent (p = 0.01). The authors called for long-term cardiovascular outcome studies before endorsing the pattern.
Human2004
The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial.
Annals of Internal Medicine
The one-year continuation of the same 132 participants. Weight minus 5.1 against minus 3.1 kg, difference minus 1.9 kg (95% CI minus 4.9 to 1.0), p = 0.20. Triglycerides fell more and HDL fell less on low carbohydrate; HbA1c improved more in the 54 with diabetes after adjustment. 34 percent dropout and suboptimal adherence.
Human2004
A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial.
Annals of Internal Medicine
120 volunteers, 24 weeks. Retention 76 against 57 percent (p = 0.02), weight minus 12.9 against minus 6.7 percent (p < 0.001), triglycerides minus 0.84 against minus 0.31 mmol/L (p = 0.004), HDL plus 0.14 against minus 0.04 (p < 0.001), LDL not significantly different (p = 0.2). The low carbohydrate arm also received nutritional supplements the comparator did not, which the authors name as a limitation.
Human2006
Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets.
American Journal of Clinical Nutrition
The trial that separates this pattern from the ketogenic one. 20 adults, six weeks, intake strictly controlled, ketosis verified. Weight 6.3 against 7.2 kg (p = 0.324) and fat loss 3.4 against 5.5 kg (p = 0.111), both favouring the non-ketogenic arm. Nothing in the controlled data requires ketosis to get the carbohydrate-restriction result.
Human2007
Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial.
JAMA
311 free-living women, twelve months, with the Atkins arm instructed to increase carbohydrate after the first two months. Atkins minus 4.7 kg, Zone minus 1.6, LEARN minus 2.6, Ornish minus 2.2. Only Atkins against Zone reached significance.
Human2018
Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.
JAMA
The same investigator, eleven years later, larger and with better diet quality in both arms. The healthy low carbohydrate arm reached 30 percent of energy from carbohydrate at twelve months, so this is a non-ketogenic trial. Between-group difference 0.7 kg (95% CI minus 0.2 to 1.6), not significant.
Human2003
A randomized trial of a low-carbohydrate diet for obesity.
New England Journal of Medicine
63 adults, one year, minimal professional contact. A large six-month advantage narrowed to minus 4.4 against minus 2.5 percent of body weight at twelve months, p = 0.26. Adherence was poor and attrition high in both groups.
Human2010
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial.
Annals of Internal Medicine
307 participants, two years, behavioural support in both arms. About 11 kg lost at one year and 7 kg at two, with no between-group difference in weight, body composition or bone mineral density at any time point. HDL was higher on low carbohydrate at every time point.
Human2014
Effects of low-carbohydrate and low-fat diets: a randomized trial.
Annals of Internal Medicine
148 adults, twelve months. Favoured low carbohydrate: weight minus 3.5 kg (p = 0.002), fat mass minus 1.5 percent (p = 0.011), triglycerides and HDL both better. No clinical cardiovascular endpoints.
Human2008
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.
New England Journal of Medicine
DIRECT. 322 adults, two years, 84.6 percent adherence, the best in this evidence base. Weight loss 4.7 kg low carbohydrate, 4.4 kg Mediterranean, 2.9 kg low fat.
Human2009
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.
New England Journal of Medicine
POUNDS LOST. 811 adults, two years, calories reduced in all arms. 65 percent against 35 percent of energy from carbohydrate produced 2.9 and 3.4 kg of weight loss, p > 0.20, with similar satiety, hunger and satisfaction. Session attendance predicted weight loss at 0.2 kg per session.
Human2010
Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies.
Annals of Internal Medicine
85,168 women over 26 years and 44,548 men over 20. An animal-based low carbohydrate score carried all-cause mortality HR 1.23 comparing extreme deciles, cardiovascular 1.14 and cancer 1.28. A vegetable-based score carried 0.80 and 0.77. Observational, and a questionnaire score is not the Atkins diet.
Human2018
Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis.
Lancet Public Health
15,428 adults over a median 25 years plus a meta-analysis of 432,179 participants. U-shaped relationship with lowest mortality at 50 to 55 percent of energy from carbohydrate. Under 40 percent HR 1.20 and over 70 percent HR 1.23. Exchanging carbohydrate for animal fat and protein gave 1.18; for plant sources, 0.82. Observational.

What people report

These are uncontrolled self-reports, not evidence. They are here because they tell you what to expect and what to watch for, which the trial literature does not. They cannot tell you whether anything works.

Rapid loss in the first one to two weeks, widely described and widely understood within the community to be mostly water and glycogen.
Appetite suppression strong enough to skip meals, the most consistently reported effect and the one the free-living trials support as the mechanism.
Triglycerides falling sharply on retest, which is the one biochemical claim the trial data supports without qualification.
LDL unchanged, which is the reported experience of most people on the non-ketogenic version and matches the randomised evidence, and a minority who see it rise, usually on the stricter induction phase.
Regain during the reintroduction phases, reported very commonly and matching the trials, where the six-month advantage is typically gone by twelve months.
No difference from any other diet, reported by people who had already reduced calories before starting.
Constipation and low energy in high-volume training, both common, both attributed to low carbohydrate and neither measured in these trials.
Difficulty eating out and social friction, the most cited reason for stopping, and less severe than for the ketogenic version because the later phases allow more carbohydrate.

Sources: r/keto and low carbohydrate communities, the long-running Atkins programme forums, and the adherence and attrition data inside the trials themselves, which is unusually well reported here: 76 against 57 percent retention in one trial, 34 percent dropout in another, and poor adherence with high attrition in both arms of a third. Uncontrolled self-report throughout.

Who this is wrong for

Anyone who came here for the ketogenic question. This entry is about carbohydrate restriction that does not maintain ketosis, and the LDL hyper-responder pattern, the euglycaemic ketoacidosis risk on SGLT2 inhibitors and the ketone measurement question all belong to the ketogenic entry.
Anyone on insulin or a sulfonylurea without a prescriber involved. The glucose-lowering effect arrives within days and is fast enough to cause hypoglycaemia before a medication review happens.
Anyone with chronic kidney disease. The most commonly studied version of this pattern runs above 20 percent of energy from protein, and the protein load is a clinical question that needs a nephrologist rather than a forum.
Anyone with a familial lipid disorder. The average LDL response across 61 trials is little to no change, and an average is not a prediction for an individual; get a panel before and about twelve weeks after starting.
Anyone expecting the difference against a normal balanced diet to be large. At matched energy it is about one kilogram, and at one to two years it is about nine hundred grams.
Anyone building the pattern around meat who takes the cohort data seriously. The animal-based version of a low carbohydrate score carries higher all-cause, cardiovascular and cancer mortality in two large cohorts, while the plant-based version carries lower, and no trial has tested that distinction.
Anyone with a history of disordered eating, for whom a phased programme built on counting a single macronutrient daily is a poor structural fit.

Questions

How is this different from keto?: Ketosis. The Atkins induction phase, under about 20 g of carbohydrate a day, is ketogenic, and the programme is designed to move you off it through three later phases. Most trials labelled low carbohydrate measure that later state: in DIETFITS the low carbohydrate arm ended at 30 percent of energy from carbohydrate. The practical difference is lipids. On this pattern LDL shows little to no change across 61 randomised trials. On the ketogenic pattern it rose in several trials and tracked with blood ketone level.
How much more weight will I lose than on a normal diet?: About a kilogram. Across 61 randomised trials and 6,925 people, with energy restriction prescribed similarly in both arms in most of them, the difference was 1.07 kg at three to eight months and 0.93 kg at one to two years. In people with type 2 diabetes it was 1.26 kg and then 0.33 kg. The review's own summary is that there is probably little to no difference up to two years.
Then why do the six-month trials look so good?: Because at six months they are good. One trial found 5.8 against 1.9 kg at six months and another found 12.9 against 6.7 percent of bodyweight at 24 weeks. The same trials at twelve months found 5.1 against 3.1 kg, p = 0.20, and the first investigator to publish a large twelve-month win published a null eleven years later with a better-designed trial. The early advantage is real and it is not durable.
What actually improves and stays improved?: Triglycerides, and HDL. Triglycerides fell 20 percent against 4 percent at six months and 0.84 against 0.31 mmol/L at 24 weeks, and those differences survived adjustment for the weight difference in the trials that tested it. HDL rose or fell less than on the comparator at every time point in a two-year trial. Those are the findings this pattern can claim without qualification.
Is a lot of it just the protein?: Probably a meaningful part of it. The Cochrane review states that its most common comparison, in 24 of 61 trials, was a low carbohydrate high protein diet, over 20 percent of energy from protein, against a control balanced across all three macronutrients. Protein independently increases satiety and preserves lean mass, so those trials measure protein and carbohydrate together and report the result as carbohydrate.